Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

507862 PANSORBIN® Cells, Lyophilized

PANSORBIN® Cells, Lyophilized MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
507862
Purchase on Sigma-Aldrich

Przegląd

Replacement Information

Products

Numer katalogowyOpakowanie Ilość/opak.
507862-1GM Ampulka plastikowa 1 gm
507862-5GM Butelka szklana 5 gm
Description
OverviewLyophilized from preparations of Cat. No. 507858. Note: size of 5 g or 1 g refers to the wet cell weight.
Catalogue Number507862
Brand Family Calbiochem®
References
ReferencesKierszenbaum, F., et al. 1991. Immunology 74, 317.
Meikle, P.J., et al. 1991. J. Biol. Chem. 266, 22569.
Ezaki, O., et al. 1989. Biochem. Biophys. Res. Commun. 159, 1368.
Murakami, H., et al. 1988. Biochem. J. 256, 917.
Kessler, S.W. 1975. J. Immunol. 115, 1617.
Product Information
FormLyophilized
FormulationLyophilized from PBS, 0.1% NaN₃.
ReconstitutionReconstitute in sterile distilled H₂O.
Quality LevelMQ100
Applications
Key Applications Enzyme Immunoassay
Immunoprecipitation
Radioimmunoassay
Biological Information
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage +2°C to +8°C
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and refrigerate (4°C). Stock solutions are stable for up to 1 month at 4°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numer katalogowy GTIN
507862-1GM 04055977271973
507862-5GM 04055977271980

Documentation

PANSORBIN® Cells, Lyophilized MSDS

Title

Safety Data Sheet (SDS) 

PANSORBIN® Cells, Lyophilized Certificates of Analysis

TitleLot Number
507862

References

Przegląd literatury
Kierszenbaum, F., et al. 1991. Immunology 74, 317.
Meikle, P.J., et al. 1991. J. Biol. Chem. 266, 22569.
Ezaki, O., et al. 1989. Biochem. Biophys. Res. Commun. 159, 1368.
Murakami, H., et al. 1988. Biochem. J. 256, 917.
Kessler, S.W. 1975. J. Immunol. 115, 1617.

Citations

Tytuł
  • Kira Steigerwald, et al. (2005) The APC tumor suppressor promotes transcription-independent apoptosis in vitro. Molecular Cancer Research 3, 78-89.
    		•
    Data Sheet

    Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

    Revision01-June-2009 JSW
    DescriptionFormalin-fixed and heat-killed Staphylococcus aureus cells bearing protein A that bind to the Fc portion of human IgG subclasses 1, 2, and 4, and to IgG from other species (binding capacity: ≥2 mg human IgG/100 mg cells). Used for many purposes, including radioimmunoassays, enzyme immunoassays, agglutination, and immunoprecipitation of antigens. PANSORBIN® also stimulates B-lymphocyte production and inhibits neoplasm growth. Lyophilized from preparations of Cat. No. 507858. Note: size of 5 g or 1 g refers to the wet cell weight.
    FormLyophilized
    FormulationLyophilized from PBS, 0.1% NaN₃.
    Intert gas (Yes/No) Packaged under inert gas
    Recommended reaction conditions
    The procedures used for performing immunoprecipitations using PANSORBIN® cells are somewhat variable, but this protocol can serve as a general guideline. PANSORBIN® cells work best when the antibody is human (IgG1, IgG2, IgG4), rabbit IgG (all isotypes), or mouse (IgG2a, IgG2b, IgG3). Prewashing: 1. Transfer desired amount of PANSORBIN® cells to a microfuge tube (typically 10-30 µl of a 10% PANSORBIN® cell suspension per immunoprecipitation). 2. Centrifuge at 3000 x g for 5 min, or at maximum speed in a microfuge for 1 min at 4°C. 3. Aspirate the supernatant. 4. Resuspend to the original volume or in 1.0 ml of cold lysis buffer, whichever is greater. Mix gently. 5. Repeat wash (steps 2-4). 6. Resuspend the final pellet to the original volume (from step 1) in lysis buffer. 7. If kept sterile, washed PANSORBIN® cells are stable at 4°C. Pre-Clearing (Optional): Pre-clearing with PANSORBIN® cells prior to immunoprecipitation removes material that binds nonspecifically, reducing the background. 1. Add 10-30 µl of washed PANSORBIN® cells to the lysate prior to incubation with the primary antibody. 2. Incubate for 1 h on ice, mixing occasionally. 3. Centrifuge at 3000 x g for 5 min, or at maximum speed in a microfuge for 1 min at 4°C. 4. Transfer the supernatant to another microfuge tube and discard the pellet. Alternatively, the lysate can be pre-cleared with PANSORBIN® cells which have been pre-bound to nonspecific antiserum (see Secondary Antibody pre-binding procedure). Primary Antibody: 1. Add the required amount of primary antibody to the lysate. 2. Incubate for at least 1 h on ice, mixing occasionally. 3. If a secondary antibody step is not required or desired, proceed to the PANSORBIN® Step described below. Secondary Antibody: In some cases, a secondary antibody will be necessary. For example, if the primary antibody is mouse IgG1, it is best to use a rabbit anti-mouse IgG as a secondary antibody. If desired, the secondary antibody can be pre-bound to the PANSORBIN® cells to eliminate the loss of antibody-antigen complexes which have not bound to the protein A. 1. Incubate the desired amount of secondary antibody with prewashed PANSORBIN® cells for 45-60 min on ice. 2. Centrifuge at 3000 x g for 5 min, or at maximum speed in a microfuge for 1 min at 4°C. 3. Aspirate the supernatant and wash the lysis buffer. 4. Resuspend in lysis buffer to a volume equal to the original volume of PANSORBIN® cells which were added. Alternatively, the unbound secondary antibody and PANSORBIN® cells can be incubated with the sample sequentially, following primary antibody incubation. PANSORBIN® Step: 1. Add at least 10X the amount of PANSORBIN® cells (alone or bound to secondary antibody) needed to precipitate the primary (or secondary) antibody. PANSORBIN® cells bind about 2 mg of human IgG/ml. Typically, add 10-30 µl of PANSORBIN® cells per immunoprecipitation. This quantity gives a visible pellet. 2. Incubate for 1-2 h on ice, mixing regularly. 3. Centrifuge at 3000 x g for 5 min, or at maximum speed in a microfuge for 1 min at 4°C. 4. Wash PANSORBIN® pellet 2-3 times with lysis buffer. 5. If samples are to be loaded onto a polyacrylamide gel, the PANSORBIN® pellet can be resuspended in sample buffer, boiled for 10 min, centrifuged quickly (30 s in a microfuge at 20°C). Load the supernatant onto the gel. If a high background is observed, it may be necessary to pre-clear lysates, prebind the antibody to PANSORBIN® cells, or use a stronger lysis buffer (e.g. RIPA). This protocol is meant to serve as a guideline and may need to be modified for specific applications.
    SolubilityReconstitution with 10 ml sterile dH₂O yields a 10% (w/v) cell suspension.
    Storage +2°C to +8°C
    Do Not Freeze Ok to freeze
    Special InstructionsFollowing reconstitution, aliquot and refrigerate (4°C). Stock solutions are stable for up to 1 month at 4°C.
    Toxicity Standard Handling
    ReferencesKierszenbaum, F., et al. 1991. Immunology 74, 317.
    Meikle, P.J., et al. 1991. J. Biol. Chem. 266, 22569.
    Ezaki, O., et al. 1989. Biochem. Biophys. Res. Commun. 159, 1368.
    Murakami, H., et al. 1988. Biochem. J. 256, 917.
    Kessler, S.W. 1975. J. Immunol. 115, 1617.
    Citation
  • Kira Steigerwald, et al. (2005) The APC tumor suppressor promotes transcription-independent apoptosis in vitro. Molecular Cancer Research 3, 78-89.
    		•